CeGaT In Brief This Week: Labcorp, Personal Genome Diagnostics, Applied DNA Sciences, Cytek, More News items for the week of Feb. 21, 2022. New Products Posted to GenomeWeb: Thermo Fisher, CDI Labs, CeGaT, More Gene Panel Analysis Refines Risky Genes in Neurodevelopmental Disorder Cases Marked by Epilepsy Investigators used gene panel sequence data to look at rare de novo variant frequencies in potential risk genes for neurodevelopmental disorders with epilepsy. HeiScreen Preps Liquid Biopsy Breast Cancer Test for Year-End Launch Premium The company's assay relies on a set of 15 methylation and microRNA markers to determine whether a woman has breast cancer. B. Braun China, CeGaT Collaborating on Clinical Genetic Testing Services in China As part of the collaboration, B. Braun China founded a subsidiary, called B. Braun Precision Medicine Technology (BBPM), that opened in Shanghai in May. Jul 16, 2018 Following Clinical Pilot Study, CeGaT Launches Genetic Disease Prevention Panel Premium Jun 20, 2017 German Genetic Dx Firm CeGaT Obtains CLIA Certification Feb 10, 2017 German Government Funds CeGaT Liquid Biopsy Research Jul 6, 2016 German Health Insurance Allows Reimbursement of NGS Tests Up to Limit; Excludes cfDNA Analysis, PGx Premium Apr 28, 2016 German Genetic Testing Firm CeGaT Eyes International Markets, Developing Liquid Biopsy Assays Premium Dec 4, 2015 Practice Sues German Reimbursement Administrator Over Unpaid Sanger Dx Tests Coupled With Free NGS Premium Jun 10, 2015 Ariosa Licenses NIPT Technology to German Startup, Others Following CE Marking of Test Algorithm Premium Jul 3, 2014 German Dx Firm Taps N-of-One to Provide Clinical Interpretation for NGS Testing Premium Jun 18, 2014 Germany's CeGaT, B. Braun Set up US Dx Subsidiary; Courting 'Large' Partner to Market Services Premium Jun 4, 2014 B Braun Medical, CeGaT Launch US Company Offering NGS-based Dx Panels Nov 13, 2013 Providers Revert to Old Techs as German Statutory Health Insurance Halts Reimbursement for NGS Tests Premium Aug 14, 2013 CeGaT Adds Somatic Tumor Analysis, Develops PGx Panel, Adopts Illumina Platforms Premium Nov 16, 2012 CLARITY Results Indicate Consensus on Clinical Bioinformatics Methods with Some Room for Improvement Premium May 2, 2012 Q&A: CeGaT's Saskia Biskup on Building an NGS-Based Clinical Sequencing Lab Premium Feb 1, 2012 B. Braun Takes 20 Percent Stake in German Diagnostics Firm CeGaT Premium Jan 4, 2011 Next-Gen Sequencing Makes Inroads into Clinical Applications in 2010 Premium Oct 26, 2010 Germany's CeGaT Offers Sequencing-Based Dx Tests on SOLiD for Range of Diseases Premium Breaking News Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study 23andMe Fiscal Q4 Revenues Increase 14 Percent Local Coverage Determinations Roundup: Castle Bio, SkylineDx Ancient Genome Sequence Provides Look at Ancestry for Individual Who Perished at Pompeii The Scan Billion-Dollar Diversity Initiative The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce. Biotech Co-Founder Arrested A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News. Return of the Tasmanian Tiger The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction. Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.